Colaneri, M.; Pieri, T.C.; Roda, S.; Ricciardi, A.; Gotti, M.; Ferrari, J.; Arcaini, L.; Rattotti, S.; Piralla, A.; Giardina, F.;
et al. Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy. J. Clin. Med. 2022, 11, 7452.
https://doi.org/10.3390/jcm11247452
AMA Style
Colaneri M, Pieri TC, Roda S, Ricciardi A, Gotti M, Ferrari J, Arcaini L, Rattotti S, Piralla A, Giardina F,
et al. Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy. Journal of Clinical Medicine. 2022; 11(24):7452.
https://doi.org/10.3390/jcm11247452
Chicago/Turabian Style
Colaneri, Marta, Teresa Chiara Pieri, Silvia Roda, Alessandra Ricciardi, Manuel Gotti, Jacqueline Ferrari, Luca Arcaini, Sara Rattotti, Antonio Piralla, Federica Giardina,
and et al. 2022. "Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy" Journal of Clinical Medicine 11, no. 24: 7452.
https://doi.org/10.3390/jcm11247452
APA Style
Colaneri, M., Pieri, T. C., Roda, S., Ricciardi, A., Gotti, M., Ferrari, J., Arcaini, L., Rattotti, S., Piralla, A., Giardina, F., Ferrari, G., Sacchi, P., Zuccaro, V., Baldanti, F., & Bruno, R.
(2022). Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy. Journal of Clinical Medicine, 11(24), 7452.
https://doi.org/10.3390/jcm11247452